MSCI China USA Biotech 65/35 Index

The MSCI China USA Biotech 65/35 Index aims to represent the performance of securities from MSCI Hong Kong Listed Southbound IMI Index and MSCI USA IMI Index with exposure to the GICS® Biotechnology Industry.
Index code
766405
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.69
P/E
52.17
P/E Fwd
36.35
P/BV
6.67
Number of constituents
40
Index Market Cap
$1.40 T
Largest constituent Market Cap
$238.88 B
Smallest constituent Market Cap
$851.20 M
Average constituent Market Cap
$35.04 B
Median constituent Market Cap
$11.74 B
Does this benchmark pursue ESG objectives?
N/A*
Data as of Aug. 31, 2026 
* For ESG objective information, please see this page

Want to learn more about MSCI indexes?
Get in touch.